ATE259803T1 - 4,5-dehydroisoxazole derivate und ihre pharmazeutische verwendung - Google Patents

4,5-dehydroisoxazole derivate und ihre pharmazeutische verwendung

Info

Publication number
ATE259803T1
ATE259803T1 AT99953847T AT99953847T ATE259803T1 AT E259803 T1 ATE259803 T1 AT E259803T1 AT 99953847 T AT99953847 T AT 99953847T AT 99953847 T AT99953847 T AT 99953847T AT E259803 T1 ATE259803 T1 AT E259803T1
Authority
AT
Austria
Prior art keywords
sup
sub
het
optionally substituted
alkyl
Prior art date
Application number
AT99953847T
Other languages
English (en)
Inventor
Eddy Jean Edgard Freyne
Jose Ignacio Andres-Gil
Frederik Dirk Deroose
Davy Petrus Franciscus M Petit
Maria E J Matesanz-Ballesteros
Escobar Rosa Maria Jan Alvarez
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of ATE259803T1 publication Critical patent/ATE259803T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/04—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
AT99953847T 1998-10-09 1999-10-07 4,5-dehydroisoxazole derivate und ihre pharmazeutische verwendung ATE259803T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP98203394 1998-10-09
PCT/EP1999/007803 WO2000021959A1 (en) 1998-10-09 1999-10-07 4,5-dihydro-isoxazole derivatives and their pharmaceutical use

Publications (1)

Publication Number Publication Date
ATE259803T1 true ATE259803T1 (de) 2004-03-15

Family

ID=8234198

Family Applications (1)

Application Number Title Priority Date Filing Date
AT99953847T ATE259803T1 (de) 1998-10-09 1999-10-07 4,5-dehydroisoxazole derivate und ihre pharmazeutische verwendung

Country Status (10)

Country Link
US (2) US6583141B1 (de)
EP (1) EP1119568B1 (de)
JP (1) JP2002527438A (de)
AT (1) ATE259803T1 (de)
AU (1) AU763460B2 (de)
CA (1) CA2346396C (de)
DE (1) DE69914931T2 (de)
ES (1) ES2216579T3 (de)
HK (1) HK1038565A1 (de)
WO (1) WO2000021959A1 (de)

Families Citing this family (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69929345T2 (de) * 1998-08-07 2006-09-21 Chiron Corp. (N.D.Ges.D. Staates Delaware), Emeryville Substituierte isoxal-derivate als östrogenrezeptormodulatoren
GB0000079D0 (en) * 2000-01-05 2000-02-23 Ferring Bv Novel antidiuretic agents
CZ20032515A3 (cs) * 2001-02-21 2003-12-17 Janssen Pharmaceutica N. V. Isoxazolinové deriváty jako anti-depresivní činidla
JP4535680B2 (ja) 2001-04-16 2010-09-01 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規１ｈ−インダゾール化合物
JPWO2003068239A1 (ja) * 2002-02-12 2005-06-02 住友製薬株式会社 新規外用剤
AR040126A1 (es) 2002-05-29 2005-03-16 Glaxo Group Ltd Compuesto de fenilsulfonilo, composicion farmaceutica que lo comprende y su uso para la elaboracion de un medicamento
TW200420573A (en) * 2002-09-26 2004-10-16 Rib X Pharmaceuticals Inc Bifunctional heterocyclic compounds and methods of making and using same
DK2910551T3 (en) 2003-04-11 2017-05-15 Ptc Therapeutics Inc 1,2,4-oxadiazole benzoic acid compounds and their use in nonsense suppression and the treatment of disease
WO2005034952A2 (en) * 2003-10-07 2005-04-21 The Feinstein Institute For Medical Research Isoxazole and isothiazole compounds useful in the treatment of inflammation
EP1632494A1 (de) 2004-08-24 2006-03-08 Ferring B.V. Vasopressin v1a antagonisten
UA89503C2 (uk) * 2004-09-13 2010-02-10 Х. Луннбек А/С Заміщені похідні аніліну
BRPI0515488A (pt) 2004-09-20 2008-07-29 Xenon Pharmaceuticals Inc derivados de heterocìclicos e seu uso como agentes terapêuticos
CN101084207A (zh) 2004-09-20 2007-12-05 泽农医药公司 杂环衍生物及其作为硬脂酰CoA去饱和酶抑制剂的用途
CA2580845A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Pyridazine derivatives for inhibiting human stearoyl-coa-desaturase
MX2007003327A (es) 2004-09-20 2007-06-05 Xenon Pharmaceuticals Inc Derivados heterociclicos, y su uso como mediadores de estearoil-coa desaturasa.
MX2007003318A (es) 2004-09-20 2007-05-18 Xenon Pharmaceuticals Inc Derivados heterociclicos y su uso como agentes terapeuticos.
AU2005286647A1 (en) 2004-09-20 2006-03-30 Xenon Pharmaceuticals Inc. Heterocyclic derivatives and their use as stearoyl-CoA desaturase inhibitors
EP2269610A3 (de) 2004-09-20 2011-03-09 Xenon Pharmaceuticals Inc. Heterozyklische Derivate und ihre Verwendung als Stearoyl-Coa-Desaturase-Inhibitoren
CN101083985A (zh) * 2004-09-21 2007-12-05 幸讬制药公司 用于炎症及免疫相关用途的化合物
CA2587678C (en) * 2004-11-16 2013-05-21 Janssen Pharmaceutica N.V. Novel heterocycle derivatives useful as selective androgen receptor modulators (sarms)
JP2009513563A (ja) 2005-06-03 2009-04-02 ゼノン・ファーマシューティカルズ・インコーポレイテッド ヒトのステアロイル−ＣｏＡデサチュラーゼ阻害剤としてのアミノチアゾール誘導体
AU2007235524B2 (en) 2006-03-30 2013-09-12 Ptc Therapeutics, Inc. Methods for the production of functional protein from DNA having a nonsense mutation and the treatment of disorders associated therewith
PT2488486T (pt) * 2009-10-13 2019-11-05 Ligand Pharm Inc Compostos de moléculas pequenas de mimética de fator de crescimento hematopoiético e utilizações dos mesmos
ES2603032T3 (es) 2010-07-15 2017-02-23 Bayer Intellectual Property Gmbh Compuestos de 3-piridil-heteroarilcarboxamida como pesticidas
CA3174516A1 (en) 2014-03-06 2015-09-11 Ptc Therapeutics, Inc. Pharmaceutical compositions and salts of a 1,2,4-oxadiazole benzoic acid
MX2018005361A (es) 2015-10-30 2018-06-07 Ptc Therapeutics Inc Metodos para tratar epilepsia.
TWI767148B (zh) 2018-10-10 2022-06-11 美商弗瑪治療公司 抑制脂肪酸合成酶(fasn)
MX2022007376A (es) 2019-12-20 2022-09-02 Tenaya Therapeutics Inc Fluoroalqull-oxadiazoles y sus usos.
CN111592522B (zh) * 2020-06-17 2022-09-09 郑州大学 一种精氨酸甲基化转移酶5小分子抑制剂及其制备方法和用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5330994A (en) * 1992-03-24 1994-07-19 Warner-Lambert Company Tetrahydropyridine isoxazoline derivatives
US5849736A (en) * 1993-11-24 1998-12-15 The Dupont Merck Pharmaceutical Company Isoxazoline and isoxazole fibrinogen receptor antagonists
WO1995014680A1 (en) * 1993-11-26 1995-06-01 Pfizer Inc. 3-aryl-2-isoxazolines as antiinflammatory agents
EP0749428B1 (de) * 1994-03-09 1998-07-29 Pfizer Inc. Isoxazoline verbindung zur hemmung tnf-freigabe
DE4408084A1 (de) 1994-03-10 1995-09-14 Hoechst Ag 3,5-Disubstituierte und 3,4,5-trisubstituierte 2-Isoxazoline und Isoxazole, Verfahren zu ihrer Herstellung und ihre Verwendung als Arzneimittel
CA2240946C (en) * 1995-12-21 2002-09-10 The Dupont Merck Pharmaceutical Company Isoxazoline, isothiazoline and pyrazoline factor xa inhibitors

Also Published As

Publication number Publication date
CA2346396A1 (en) 2000-04-20
AU1039300A (en) 2000-05-01
DE69914931T2 (de) 2004-12-16
EP1119568A1 (de) 2001-08-01
US6583141B1 (en) 2003-06-24
AU763460B2 (en) 2003-07-24
HK1038565A1 (en) 2002-03-22
US7414048B2 (en) 2008-08-19
JP2002527438A (ja) 2002-08-27
WO2000021959A1 (en) 2000-04-20
EP1119568B1 (de) 2004-02-18
US20040019059A1 (en) 2004-01-29
DE69914931D1 (de) 2004-03-25
CA2346396C (en) 2009-04-28
ES2216579T3 (es) 2004-10-16

Similar Documents

Publication Publication Date Title
ATE259803T1 (de) 4,5-dehydroisoxazole derivate und ihre pharmazeutische verwendung
DK1533292T3 (da) Dibenzylaminforbindelse og medicinsk anvendelse deraf
NO20004485D0 (no) Sykloalkenderivater, deres fremstilling og anvendelse
ATE220066T1 (de) Benzimidazole derivate als cyclooxygenase-2 inhibitoren
HUP9701605A2 (hu) Helyettesített bifenil- vagy fenil-piridin-származékok, eljárás előállításukra és a vegyületeket tartalmazó gyógyászati készítmények
JO2644B1 (en) Derivatives of N- (amino-aryl mixture) -H1- indole-2-carboxamide Synthesis and therapeutic use
BG104248A (en) Benzamidoxim derivatives, intermediate products and methods for preparing and using them as fungicides
TW200612920A (en) Novel imidazolidine derivatives
HUP0201646A2 (hu) Új alfa-aminosav vegyületek, eljárás ezek előállítására, és ezeket tartalmazó gyógyászati készítmények
JP2005510476A5 (de)
MA27651A1 (fr) Nouveaux derives d'uree cyclique, leur preparation et leur utilisation pharmaceutique comme inhibiteurs de kinases
HK1111999A1 (en) Spiroketal derivative and use thereof as diabetic medicine
ZA200810739B (en) Pesticide containing novel pyridyl-methanamine derivative or its salt
CA2167673A1 (en) Condensed benzazepine derivative and pharmaceutical composition thereof
TW200635896A (en) N-(heteroaryl)-1H-indole-2-carboxamide derivatives, preparation thereof and therapeutic application thereof
WO2008153042A1 (ja) 抗腫瘍剤
ATE305930T1 (de) Substituierte benzopyran derivate gegen arrhythmie
ATE166055T1 (de) 5h,10h-imidazo(1,2-a>indeno(1,2-e>pyrazin-4-one derivate, ihre herstellung und die sie enthaltenden arzneimittel
NZ221699A (en) Pyridazinone derivatives; pharmaceutical compositions and intermediates
NO20071708L (no) 4((2,4-diklor-5-metoksyfenyl) amino)-6-alkoksy-7-etynyl-3-kinolinkarbonitriler for behandling av ischemisk skade.
DE60104949D1 (de) Heilmittel für diabetes welche 2-(n-cyanoimino)thiazolidine-4-one derivate enthalten
DE60144246D1 (de) Imidazolderivate, verfahren zu deren herstellung und deren verwendung
JP2004518633A5 (de)
WO2001044197A3 (fr) Derives de 2-phenyl-quinoleine et leur utilisation en tant qu'agent contractant des muscles lisses
KR940018362A (ko) 니코틴산 유도체

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties